Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III pediatric noninferiority study of CSL influenza vaccine versus Fluzone
2014-003768-19Phase 3
- Sponsor
- CSL Limited
- Start
- Jan 2015
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial in influenza comparing CSL Influenza Virus Vaccine with Fluzone (2 arms). Primary endpoint: Geometric mean titer 30 days after the last study vaccination.
02
Drugs
Fluzone TrivalentAfluria
03
Conditions
influenza
Beyond the preview
Go deeper on 2014-003768-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-003768-19.